PRL and arthritic joint disease: Experimental studies showed that increasing prolactinemia, either by PRL infusion or treatment with the dopamine D2 receptor blocker haloperidol, ameliorates the severity of arthritis, either directly (42) or via the PRL conversion to antiangiogenic vasoinhibin (25) (Figure 2).